Skip to content

An exploratory study to assess the accuracy and safety of continuous ketone monitoring devices for measurement in different glucose tolerance populations using experimental test systems as a reference

An exploratory study to assess the accuracy and safety of continuous ketone monitoring devices for measurement in different glucose tolerance populations using experimental test systems as a reference

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096428
Enrollment
Unknown
Registered
2025-01-23
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose tolerance, diabetes mellitus

Interventions

Gold Standard:Serum ketone levels measured by laboratory methods
Index test:Subcutaneous implantable continuous tissue ketone monitoring device

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. According to the WHO 2019 classification criteria for glucose metabolism, patients with normal glucose metabolism, abnormal glucose regulation, and diabetic patients diagnosed with OGTT; 2. Subjects aged 18 to 80 years, male and female subjects (including 18 and 80 years old); 3.BMI>=24Kg/m^2; 4. Agree to participate in this study and sign the Informed Consent Form (ICF).

Exclusion criteria

Exclusion criteria: 1. Patients with unstably controlled severe cardiovascular disease, hepatic or renal dysfunction, or a combination of uncontrolled severe ketoacidosis, or the presence of a serious infection; 2. Patients who are not readily cooperative, have psychiatric disorders that interfere with informed consent and/or AE presentation or observation; 3. Subjects with blood triglycerides > 500 mg/dL or > 5.7 mmol/L (based on CTCAE version 5.0) 4. Subjects with blood cholesterol > 400 mg/dL or > 10.34 mmol/L (based on CTCAE version 5.0); 5. Female subjects who are breastfeeding or have a positive pregnancy test result at the time of the Screening Examination; 6. Subjects who have participated in another clinical trial within 1 month prior to the Screening Examination; 7. Those who are considered by the investigator to be inappropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Ketone (serum, capillary, tissue);serum c peptide;

Secondary

MeasureTime frame
Glucose (plasma, capillary, tissue);serum insulin;Biochemistry (liver and kidney function);HbA1c;

Countries

China

Contacts

Public ContactLi Ang

Peking University First Hospital

liang850513@hotmail.com+86 136 8133 8795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026